PCV90 THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS...

PCV90 THE COST-EFFECTIVENESS OF ROSUVASTATIN VERSUS SIMVASTATIN FOR THE PREVENTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH HIGH BASELINE RISK—A SWEDISH ECONOMIC EVALUATION BASED UPON THE JUPITER TRIAL

AG Olsson, MM Jensen, SK Gandhi, L Smolen, T Paulsson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72432-9
File:
PDF, 77 KB
english, 2010
Conversion to is in progress
Conversion to is failed